摘要
白细胞介素-19(Interleukin-19,IL-19)是近年来新发现的白细胞介素-10(IL-10)超家族的细胞因子。IL-10普遍被认为是系统性抑制炎症的细胞因子,而IL-19与IL-10序列和结构相似,因此过去认为二者具有相似的生物学活性,但随后有许多研究证明,IL-19的生物学作用与IL-10有诸多不同,并且IL-19在不同系统的疾病中尤其是炎症反应方面也具有不同作用。国内外学者就IL-19在部分炎症性疾病中的发病机制、作为潜在治疗靶点的可行性做了不少研究,现就近年来IL-19在心血管、呼吸等系统炎症性疾病中的作用机制及其研究进展做一综述。
Interleukin-19(IL-19)is a newly discovered cytokine of the interleukin-10(IL-10)superfamily.IL-10 is generally considered to be a systemic cytokine that inhibits inflammation,whereas IL-19 is similar to IL-10's sequence and structure,so it's been thought that both have similar biological activities,but many studies have shown that the biological effects of IL-19 are different from those of IL-10,and IL-19 also has different effects in different systems of diseases,especially in inflammatory response.Researchers have done a lot of research on the pathogenesis of IL-19 in some inflammatory diseases and feasibility of being apotential therapeutic target.The main goal of this review is to discuss the underlying mechanisms and research progress in cardiovascular,respiratory and other inflammatory diseases.
作者
王锟琨
万春
文富强
WANG Kunkun;reviewing;WAN Chun;WEN Fuqiang(West China School of Medicine, Sichuan University, Chengdu 610041, China;Department of Respiratory, West China Hospital, Sichuan University, Chengdu 610041, China)
出处
《西部医学》
2018年第7期1079-1081,1087,共4页
Medical Journal of West China
基金
四川大学青年教师科研启动基金(2015SCU11999-10)
四川省大学生创新创业训练计划项目(201710611785)